Gainers & Losers : Equity - Pharma

Absolute Returns (in %)  as on Jun 19, 2018
Listed below are the schemes in the selected category based on their 1 year return. Use the adjacent drop down menu to view the schemes based on their Absolute or Annualised Returns or Ranks.
Mutual Fund Scheme Asset (Rs. cr.) NAV 1 wk 1 mth 3 mth 6 mth 1 yr 2 yr 3 yr 5 yr
Reliance Pharma Fund - Direct (G) 1,927.84 151.38 3.5 6.1 7.5 3.1 14.6 13.5 13.4 113.0
Reliance Pharma Fund (G) 1,927.84 144.76 3.5 6.0 7.2 2.7 13.6 11.5 10.4 104.4
UTI Healthcare Fund - D (G) 384.58 88.30 2.2 5.2 0.5 -4.1 2.5 -0.4 -5.7 75.9
Tata India Pharma & HealthCare -Dir (G) 133.07 9.00 2.4 4.5 3.8 0.2 2.0 -1.6 -- --
UTI Healthcare Fund (G) 384.58 84.16 2.1 5.1 0.2 -4.5 1.5 -2.2 -8.3 68.3
Tata India Pharma & HealthCare - RP (G) 133.07 8.63 2.4 4.3 3.3 -0.7 0.2 -5.0 -- --
SBI Healthcare Opportunities - D (G) 914.15 124.04 2.6 3.0 -2.1 -9.2 -4.9 -9.9 -11.7 94.1
SBI Healthcare Opportunities (G) 914.15 116.84 2.6 2.9 -2.4 -9.8 -6.1 -12.1 -14.9 83.5